Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding. Read more about Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding.
Structure-based design of an in vivo active selective BRD9 inhibitor. Read more about Structure-based design of an in vivo active selective BRD9 inhibitor.
Structural basis for a novel interaction between TXNIP and Vav2. Read more about Structural basis for a novel interaction between TXNIP and Vav2.
Structural Basis for Substrate Preference of SMYD3, A SET Domain-containing Protein Lysine Methyltransferase. Read more about Structural Basis for Substrate Preference of SMYD3, A SET Domain-containing Protein Lysine Methyltransferase.
Family-wide characterization of histone binding abilities of human CW domain containing proteins. Read more about Family-wide characterization of histone binding abilities of human CW domain containing proteins.
Using a Genetically Encoded Sensor to Identify Inhibitors of Toxoplasma gondii Ca2+ Signalling. Read more about Using a Genetically Encoded Sensor to Identify Inhibitors of Toxoplasma gondii Ca2+ Signalling.
The Intersection of Structural and Chemical Biology - An Essential Synergy. Read more about The Intersection of Structural and Chemical Biology - An Essential Synergy.
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds. Read more about Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. Read more about System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes.
Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1). Read more about Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1).
